Innovate Biopharmaceuticals, Inc. added to membership of Russell 3000®, 2000® and the Russell Microcap® Indexes
25 juin 2018 10h30 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 25, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc. (NASDAQ:INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and...
Innovate Biopharmaceuticals Announces Appointment of Saira Ramasastry to Board of Directors and Resignation of Anna Kazanchyan, M.D.
13 juin 2018 19h10 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 13, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Scheduled to Present at the Jefferies Global Healthcare Conference in New York on Friday, June 8, 2018, at 11:30AM
31 mai 2018 07h02 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., May 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Scheduled to Present at BIO 2018 Convention in Boston on Tuesday, June 5, 2018, at 4:45PM
22 mai 2018 08h01 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Celiac Disease KOL and Management Meetings around the Digestive Disease Week (DDW) conference on Monday, June 4, 2018, in Washington, D.C.
17 mai 2018 15h06 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Reports First Quarter 2018 Key Financial and Corporate Highlights
16 mai 2018 09h10 HE
|
Innovate Biopharmaceuticals, Inc
Further data on larazotide’s mechanism of action, dose response and pharmacology expected at DDW (June 2-5) in Washington D.C.Addition to senior management of June Almenoff, M.D., PhD. as COO and CMO...
Innovate Biopharmaceuticals Announces Acceptance of Two Abstracts for the Digestive Disease Week 2018 Conference
09 mai 2018 14h07 HE
|
Innovate Biopharmaceuticals, Inc
Highlighting the Dose Response and Mechanism of Action of Larazotide Acetate In large animals, larazotide replicated its mechanism of action by renormalizing the dysfunctional intestinal barrierIn...
Innovate Biopharmaceuticals, Inc. to Present at the H.C. Wainwright Annual Global Life Sciences Conference on April 9, 2018
05 avr. 2018 06h03 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., April 05, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer
13 mars 2018 07h32 HE
|
Innovate Biopharmaceuticals, Inc
Dr. Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and from Furiex Pharmaceuticals, where as President and Chief Medical Officer, she oversaw the...
Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at the Cowen Healthcare Conference on March 13, 2018, Tuesday at 8:40 AM ET
07 mars 2018 07h32 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...